0001209191-23-015514.txt : 20230303
0001209191-23-015514.hdr.sgml : 20230303
20230303163012
ACCESSION NUMBER: 0001209191-23-015514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gao Hanlin
CENTRAL INDEX KEY: 0001684532
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37894
FILM NUMBER: 23704575
MAIL ADDRESS:
STREET 1: 2325 CLUB VISTA DRIVE
CITY: GLENDORA
STATE: CA
ZIP: 91741
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulgent Genetics, Inc.
CENTRAL INDEX KEY: 0001674930
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 812621304
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205
CITY: TEMPLE CITY
STATE: CA
ZIP: 91780
BUSINESS PHONE: 626-350-0537
MAIL ADDRESS:
STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205
CITY: TEMPLE CITY
STATE: CA
ZIP: 91780
FORMER COMPANY:
FORMER CONFORMED NAME: Fulgent Diagnostics, Inc.
DATE OF NAME CHANGE: 20160517
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-01
0
0001674930
Fulgent Genetics, Inc.
FLGT
0001684532
Gao Hanlin
C/O FULGENT GENETICS, INC.
4978 SANTA ANITA AVE, STE 205
TEMPLE CITY
CA
91780
0
1
0
0
Chief Scientific Officer
Common Stock
2023-03-01
4
F
0
3804
31.85
D
915812
D
The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.
/s/ Paul Kim as Attorney-in-Fact
2023-03-03